Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.

Publication

Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.

Journal Paper/Review - Dec 15, 2021

Fankhauser Christian D, Christiansen Ailsa J, Rothermundt Christian, Cathomas Richard, Wettstein Marian S, Grossmann Nico C, Grogg Josias B, Templeton Arnoud J, Hirschi-Blickenstorfer Anita, Lorch Anja, Gillessen Silke, Moch Holger, Beyer Joerg, Hermanns Thomas

Citation

Fankhauser C, Christiansen A, Rothermundt C, Cathomas R, Wettstein M, Grossmann N, Grogg J, Templeton A, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. Br J Cancer 2021; 126:1140-1144.

Type

Journal Paper/Review (English)

Journal

Br J Cancer 2021; 126

Publication Date

Dec 15, 2021

Issn Electronic

1532-1827

Pages

1140-1144

Brief description/objective

MiR-371a-3p predicts the presence of a macroscopic non-teratomatous germ cell tumour (GCT). We hypothesised that miR-371a-3p can also detect recurrence during active surveillance (AS) of stage I GCT.